Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 21 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

17%

2 of 12 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (9)
Early P 1 (1)
P 3 (1)

Trial Status

Completed12
Unknown3
Not Yet Recruiting2
Recruiting2
Enrolling By Invitation1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT07419581Not ApplicableNot Yet RecruitingPrimary

A Study of Freeze-Dried Miracle Fruit (MiraBurst) on Participants Receiving Cancer Treatment

NCT02304913Not ApplicableRecruiting

Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy

NCT07498062Not ApplicableCompleted

Multimodal Chewing Gum Flavour Training to Aid Flavour Perception Recovery - a Pilot Study.

NCT07317752Not Yet Recruiting

Incidence of Dysgeusia in Breast Cancer Patients Undergoing Chemotherapy

NCT06311877Not ApplicableEnrolling By InvitationPrimary

Effects of Flavor Modification for Management of Radiation Induced Dysgeusia

NCT05486260Not ApplicableCompleted

Effect of Dried Miracle Berry on the Olfactory-gustative Perception in Malnourished Cancer Patients

NCT04791436Recruiting

Oral and Olfactory Complications of Recovered COVID-19 Patients

NCT01540045Completed

Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer

NCT05868850Not ApplicableCompletedPrimary

Application of Auricular Point Sticking in Patients With Taste Alteration

NCT05812209Completed

Stellate Ganglion Block to Treat Long COVID 19 Case Series

NCT05760079Not ApplicableWithdrawn

Lactoferrin for COVID-19-Induced Taste or Smell Abnormality

NCT04384042Unknown

Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study

NCT04390165Completed

Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study

NCT04473157Completed

COVID-19 in Patients With Anosmia in Egypt

NCT04629560Early Phase 1Completed

Miracle Fruit Powder for the Treatment of Taste Alterations Secondary to Chemotherapy

NCT04543175Completed

Taste Disorders and Their Relation to BMI, FFQ, and EORTC QLQ-BR23 in Breast Cancer Patients During Chemotherapy.

NCT02475928Not ApplicableUnknownPrimary

Zinc Supplementation in Cirrhotic Patients

NCT01097915CompletedPrimary

Gustin Gene Polymorphism and 6-n-propylthiouracil (PROP) Taste

NCT01596634Not ApplicableCompleted

Bovine Lactoferrin in Reducing Taste Disturbances in Patients With Colorectal Cancer Receiving Oxaliplatin-Based Chemotherapy

NCT03210441Unknown

Evaluation of Eating Habits and Dysgeusia During Chemotherapy Treatment in Patients Affected by Breast Cancer

Scroll to load more

Research Network

Activity Timeline